Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
CardioVascular and Interventional Radiology
Published in: CardioVascular and Interventional Radiology 2/2017

01-02-2017 | CIRSE Standards of Practice Guidelines

CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma

Authors: Miltiadis E. Krokidis, Franco Orsi, Konstantinos Katsanos, Thomas Helmberger, Andy Adam

Published in: CardioVascular and Interventional Radiology | Issue 2/2017

Login to get access

Excerpt

Renal cell carcinoma (RCC) comprises approximately 3.8% of all new cancers in the western world; the detection rate of RCC has been increasing in the past 10 years by approximately 1.7% per year [1]. This rise is attributed to the increased number of diagnostic cross-sectional scans in which asymptomatic renal tumours are incidentally detected. The median age at diagnosis is 64 years [2]. …
Literature
1.
2.
3.
Choyke PL, Glenn GM, Walther MM, Zbar B, Linehan WM. Hereditary renal cancers. Radiology. 2003;226:33–46.PubMedCrossRef
4.
DeVita Jr VT, Lawrence TS, Rosenberg SA, editors. Cancer: principles and practice of oncology. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.
5.
Shuch B, Amin A, Armstrong AJ, Eble JN, Ficarra V, Lopez-Beltran A, et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biological complexity. Eur Urol. 2015;67:85–97.PubMedCrossRef
6.
Bex A. Classification of renal cell carcinoma subtypes: there is more than meets the eye. Eur Urol. 2015;67:98–9.PubMedCrossRef
7.
Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6(7):655–63.PubMedCrossRef
8.
Eble JN, Sauter G, Epstein JI, Sesterhenn IA, editors. Pathology and genetics of tumours of the urinary system and male genital organs. World Health Organization Classification of Tumours. Lyon: IARC Press; 2004. p. 7.
9.
Srigley JR, Delahunt B, Eble JN, Egevad L, Epstein JI, Grignon D, et al. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. Am J Surg Pathol. 2013;37:1469–89.PubMedCrossRef
10.
Israel GM, Bosniak MA. Pitfalls in renal mass evaluation and how to avoid them. Radiographics. 2008;28(5):1325–38.PubMedCrossRef
11.
Zagoria RJ, Dyer RB, Wolfman NT, Hinn GC, Chen YM. Radiology in the diagnosis and staging of renal cell carcinoma. Crit Rev Diagn Imaging. 1990;31(1):81–115.PubMed
12.
Choudhary S, Rajesh A, Mayer NJ, Mulcahy KA, Haroon A. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol. 2009;64(5):517–22.PubMedCrossRef
13.
Millet I, Doyon FC, Hoa D, Thuret R, Merigeaud S, Serre I, et al. Characterization of small solid renal lesions: can benign and malignant tumors be differentiated with CT? AJR. 2011;197:887–96.PubMedCrossRef
14.
Rosenkrantz AB, Hindman N, Fitzgerald EF, Niver BE, Melamed J, Babb JS. MRI features of renal oncocytoma and chromophobe renal cell carcinoma. AJR Am J Roentgenol. 2010;195(6):W421–7.PubMedCrossRef
15.
Hindman N, Ngo L, Genega EM, Melamed J, Wei J, Braza JM, et al. Angiomyolipoma with minimal fat: can it be differentiated from clear cell renal cell carcinoma by using standard MR techniques? Radiology. 2012;265(2):468–77.PubMedPubMedCentralCrossRef
16.
Pedrosa I, Sun MR, Spencer M, Genega EM, Olumi AF, Dewolf WC, et al. MR imaging of renal masses: correlation with findings at surgery and pathologic analysis. Radiographics. 2008;28(4):985–1003.PubMedCrossRef
17.
Putra LG, Minor TX, Bolton DM, Appu S, Dowling CR, Neerhut GJ. Improved assessment of renal lesions in pregnancy with magnetic resonance imaging. Urology. 2009;74(3):535–9.PubMedCrossRef
18.
Lanzman RS, Robson PM, Sun MR, Patel AD, Mentore K, Wagner AA, et al. Arterial spin-labeling MR imaging of renal masses: correlation with histopathologic findings. Radiology. 2012;265(3):799–808.PubMedPubMedCentralCrossRef
19.
Capitanio U, Montorsi F. Renal cancer. Lancet. 2015. (epub ahead of print).
20.
21.
Maxwell NJ, Saleem AN, Rogers E, Kiely D, Sweeney P, Brady AP. Renal artery embolisation in the palliative treatment of renal carcinoma. Br J Radiol. 2007;80(950):96–102.PubMedCrossRef
22.
Guy L, Alfidja AT, Chabrot P, Ravel A, Boiteux JP, Boyer L. Palliative transarterial embolization of renal tumors in 20 patients. Int Urol Nephrol. 2007;39(1):47–50.PubMedCrossRef
23.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.PubMedCrossRef
24.
McKiernan J, Simmons R, Katz J, Russo P. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology. 2002;59:816–20.PubMedCrossRef
25.
Huang WC, Elkin EB, Levey AS, Jang TL, Russo P. Partial nephrectomy vs. radical nephrectomy in patients with small renal tumors—is there a difference in mortality and cardiovascular outcomes? J Urol. 2009;181(1):55–61.PubMedCrossRef
26.
Zini L, Perrotte P, Capitanio U, Jeldres C, Shariat SF, Antebi E, et al. Radical versus partial nephrectomy: effect on overall and noncancer mortality. Cancer. 2009;115(7):1465–71.PubMedCrossRef
27.
Thompson RH, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, Cheville JC, et al. Radical nephrectomy for pT1a renal masses may be associated with decreased overall survival compared with partial nephrectomy. J Urol. 2008;179(2):468–71.PubMedCrossRef
28.
Patard JJ, Bensalah KC, Pantuck AJ, Klatte T, Crepel M, Verhoest G, et al. Radical nephrectomy is not superior to nephron sparing surgery in PT1B-PT2N0M0 renal tumours: A matched comparison analysis in 546 cases. Eur Urol Suppl. 2008;7(3):194.CrossRef
29.
Kutikov A, Uzzo RG. The RENAL nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844–53.PubMedCrossRef
30.
Ficarra V, Novara G, Secco S, Macchi V, Porzionato A, De Caro R, et al. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol. 2009;56(5):786–93.PubMedCrossRef
31.
Simmons MN, Ching CB, Samplaski MK, Park CH, Gill IS. Kidney tumor location measurement using the C index method. J Urol. 2010;183(5):1708–13.PubMedCrossRef
32.
Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175(2):425–31.PubMedCrossRef
33.
Rais-Bahrami S, Guzzo TJ, Jarrett TW, Kavoussi LR, Allaf ME. Incidentally discovered renal masses: oncological and perioperative outcomes in patients with delayed surgical intervention. BJU Int. 2009;103:1355–8.PubMedCrossRef
34.
Bosniak MA, Birnbaum BA, Krinsky GA, Waisman J. Small renal parenchymal neoplasms: further observations on growth. Radiology. 1995;197:589–97.PubMedCrossRef
35.
Oda T, Miyao N, Takahashi A, Yanase M, Masumori N, Itoh N, et al. Growth rates of primary and metastatic lesions of renal cell carcinoma. Int J Urol. 2001;8:473–7.PubMedCrossRef
36.
Guðmundsson E, Hellborg H, Lundstam S, Erikson S, Ljungberg B, Swedish Kidney Cancer Quality Register Group. Metastatic potential in renal cell carcinomas ≤7 cm: Swedish Kidney Cancer Quality Register data. Eur Urol. 2011;60(5):975–82.PubMedCrossRef
37.
McGovern FJ, Wood BJ, Goldberg SN, Mueller PR. Radiofrequency ablation of renal cell carcinoma via image guided needle electrodes. J Urol. 1999;161(2):599–600.PubMedCrossRef
38.
Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma. Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR. 2005;185:64–71.PubMedCrossRef
39.
Zagoria RJ, Hawkins AD, Clark PE, Hall MC, Matlaga BR, Dyer RB, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR. 2004;183:201–7.PubMedCrossRef
40.
Georgiades CS, Rodriguez R. Efficacy and safety of percutaneous cryoablation for stage 1A/B renal cell carcinoma: results of a prospective, single-arm, 5-year study. Cardiovasc Interv Radiol. 2014;37(6):1494–9.CrossRef
41.
Breen D, Bryant TJ, Abbas A, Shepherd B, McGill N, Anderson JA, et al. Percutaneous cryoablation of renal tumours: outcomes from 171 tumours in 147 patients. BJU Int. 2013;112(6):758–65.PubMedCrossRef
42.
Schmit GD, Schenck LA, Thompson RH, Boorjian SA, Kurup AN, Weisbrod AJ, et al. Predicting renal cryoablation complications: new risk score based on tumor size and location and patient history. Radiology. 2014;272(3):903–10.PubMedCrossRef
43.
Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–24.PubMedCrossRef
44.
Escudier B, Porta C, Schmidinger M, Algaba F, Patard JJ, Khoo V, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2014;25(Suppl 3):49–56.CrossRef
45.
46.
Schmit GD, Kurup AN, Weisbrod AJ, Thompson RH, Boorjian SA, Wass CT, et al. ABLATE: a renal ablation planning algorithm. AJR Am J Roentgenol. 2014;202(4):894–903.PubMedCrossRef
47.
Warshauer DM, McCarthy SM, Street L, Bookbinder MJ, Glickman MG, Richter J, et al. Detection of renal masses: sensitivities and specificities of excretory urography/linear tomography, US, and CT. Radiology. 1988;169(2):363–5.PubMedCrossRef
48.
Paudice N, Zanazzi M, Agostini S, Bertelli E, Caroti L, Carta P, et al. Contrast-enhanced ultrasound assessment of complex cystic lesions in renal transplant recipients with acquired cystic kidney disease: preliminary experience. Transplant Proc. 2012;44(7):1928–9.PubMedCrossRef
49.
Sahni VA, Silverman G. Imaging management of incidentally detected small renal masses. Semin Interv Radiol. 2014;31:9–19.CrossRef
50.
Grobner T. Gadolinium–a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21(4):1104–8.PubMedCrossRef
51.
52.
Tsiviam M, Rampersaud Jr EN, del Pilar Laguna Pes M, Joniau S, Leveillee RJ, Shingleton WB, et al. Small renal mass biopsy–how, what and when: report from an international consensus panel. BJU Int. 2014;113(6):854–63.CrossRef
53.
Breda A, Treat EG, Haft-Candell L, Leppert JT, Harper JD, Said J, et al. Comparison of accuracy of 14-, 18- and 20-G needles in ex vivo renal mass biopsy: a prospective, blinded study. BJU Int. 2010;105(7):940–5.PubMedCrossRef
54.
Veltri A, Garetto I, Tosetti I, Busso M, Volpe A, Pacchioni D, et al. Diagnostic accuracy and clinical impact of imaging-guided needle biopsy of renal masses. Retrospective analysis on 150 cases. Eur Radiol. 2011;21(2):393–401.PubMedCrossRef
55.
Uppot RN, Silverman SG, Zagoria RJ, Tuncali K, Childs DD, Gervais DA. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol. 2009;192(6):1558–70.PubMedCrossRef
56.
Breen DJ, Railton NJ. Minimally invasive treatment of small renal tumors: trends in renal cancer diagnosis and management. Cardiovasc Interv Radiol. 2010;33(5):896–908.CrossRef
57.
Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727–36.PubMedCrossRef
58.
Goldberg SN, Gazelle GS. Radiofrequency tissue ablation: physical principles and techniques for increasing coagulation necrosis. Hepatogastroenterology. 2001;48:359–67.PubMed
59.
Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–9.PubMedCrossRef
60.
Veltri A, De Fazio G, Malfitana V, Isolato G, Fontana D, Tizzani A, et al. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients. Eur Radiol. 2004;14:2303–10.PubMedCrossRef
61.
Georgiades C, Rodriguez R, Azene E, Weiss C, Chaux A, Gonzalez-Roibon N, et al. Determination of the nonlethal margin inside the visible “ice-ball” during percutaneous cryoablation of renal tissue. Cardiovasc Interv Radiol. 2013;36(3):783–90.CrossRef
62.
Weld KJ, Hruby G, Humphrey PA, Ames CD, Landman J. Precise characterization of renal parenchymal response to single and multiple cryoablation probes. J Urol. 2006;176(2):784–6.PubMedCrossRef
63.
Campbell SC, Krishnamurthi V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery: experimental evaluations of treatment parameters. Urology. 1998;52(1):29–34.PubMedCrossRef
64.
Lubner MG, Brace CL, Ziemlewicz TJ, Hinshaw JL, Lee Jr FT. Microwave ablation of hepatic malignancy. Semin Interv Radiol. 2013;30(1):56–66.CrossRef
65.
Liang P, Wang Y. Microwave ablation of hepatocellular carcinoma. Oncology. 2007;72(Suppl 1):124–31.PubMedCrossRef
66.
Wright AS, Sampson LA, Warner TF, Mahvi DM, Lee Jr FT. Radiofrequency versus microwave ablation in a hepatic porcine model. Radiology. 2005;236:132–9.PubMedCrossRef
67.
Knavel EM, Hinshaw JL, Lubner MG, Andreano A, Warner TF, Lee Jr FT, et al. High-powered gas-cooled microwave ablation: shaft cooling creates an effective stick function without altering the ablation zone. AJR Am J Roentgenol. 2012;198:W260–5.PubMedPubMedCentralCrossRef
68.
Cheng Z, Xiao Q, Wang Y, Sun Y, Lu T, Liang P. 915 MHz microwave ablation with implanted internal cooled-shaft antenna: initial experimental study in in vivo porcine livers. Eur J Radiol. 2011;79:131–5.PubMedCrossRef
69.
Horn JC, Patel RS, Kim E, Nowakowski FS, Lookstein RA, Fischman AM. Percutaneous microwave ablation of renal tumors using a gas-cooled 2.4-GHz probe: technique and initial results. J Vasc Interv Radiol. 2014;25(3):448–53.PubMedCrossRef
70.
Wah TM, Irving HC. Infectious complications after percutaneous radiofrequency ablation of renal cell carcinoma in patients with ileal conduit. J Vasc Interv Radiol. 2008;19(9):1382–5.PubMedCrossRef
71.
Fotiadis NI, Sabharwal T, Morales JP, Hodgson DJ, O’Brien TS, Adam A. Combined percutaneous radiofrequency ablation and ethanol injection of renal tumours: midterm results. Eur Urol. 2007;52(3):777–84.PubMedCrossRef
72.
Krokidis M, Spiliopoulos S, Jarzabek M, Fotiadis N, Sabharwal T, O’Brien T, et al. Percutaneous radiofrequency ablation of small renal tumours in patients with a single functioning kidney: long-term results. Eur Radiol. 2013;23(7):1933–9.PubMedCrossRef
73.
Boss A, Clasen S, Kuczyk M, Anastasiadis A, Schmidt D, Graf H, et al. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study. Invest Radiol. 2005;40:583–90.PubMedCrossRef
74.
Gupta A, Allaf ME, Kavoussi LR, Jarrett TW, Chan DY, Su LM, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175:447–52.PubMedCrossRef
75.
Miki K, Shimomura T, Yamada H, Kishimoto K, Ohishi Y, Harada J, et al. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging. Int J Urol. 2006;13:880–4.PubMedCrossRef
76.
Park BK, Kim SH, Byun JY, Kim YS, Kwon GY, Jang IS. CT-guided instillation of 5% dextrose in water into the anterior pararenal space before renal radiofrequency ablation in a porcine model: positive and negative effects. J Vasc Interv Radiol. 2007;18:1561–9.PubMedCrossRef
77.
Kam AW, Littrup PJ, Walther MM, Hvizda J, Wood BJ. Thermal protection during percutaneous thermal ablation of renal cell carcinoma. J Vasc Interv Radiol. 2004;15(7):753–8.PubMedPubMedCentralCrossRef
78.
Wah TM, Koenig P, Irving HC, Gervais DA, Mueller PR. Radiofrequency ablation of a central renal tumour: protection of the collecting system with a retrograde cold dextrose pyeloperfusion technique. J Vasc Interv Radiol. 2005;16(11):1551–5.PubMedCrossRef
79.
Cantwell CP, Wah TM, Gervais DA, Eisner BH, Arellano R, Uppot RN, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol. 2008;19(7):1034–40.PubMedCrossRef
80.
Tacke J, Mahnken A, Bucker A, Rohde D, Gunther RW. Nephron-sparing percutaneous ablation of a 5 cm renal cell carcinoma by superselective embolization and percutaneous RF-ablation. Rofo. 2001;173:980–3.PubMedCrossRef
81.
Tacke J, Mahnken AH, Gunther RW. Percutaneous thermal ablation of renal neoplasms. Rofo. 2005;177:1631–40.PubMedCrossRef
82.
Mahnken AH, Penzkofer T, Bruners P, Günther RW, Brehmer B. Interventional management of a renal cell carcinoma by radiofrequency ablation with tagging and cooling. Korean J Radiol. 2009;10(5):523–6.PubMedPubMedCentralCrossRef
83.
Meloni MF, Bertolotto M, Alberzoni C, Lazzaroni S, Filice C, Livraghi T, et al. Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol. 2008;191(4):1233–8.PubMedCrossRef
84.
Rutherford EE, Cast JE, Breen DJ. Immediate and long-term CT appearances following radiofrequency ablation of renal tumours. Clin Radiol. 2008;63(2):220–30.PubMedCrossRef
85.
86.
Merkle EM, Nour SG, Lewin JS. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months. Radiology. 2005;235:1065–71.PubMedCrossRef
87.
88.
Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol. 2013;63(3):486–92.PubMedCrossRef
89.
Lane BR, Campbell SC, Gill IS. 10-year oncologic outcomes after laparoscopic and open partial nephrectomy. J Urol. 2013;190(1):44–9.PubMedCrossRef
90.
Katsanos K, Mailli L, Krokidis M, McGrath A, Sabharwal T, Adam A. Systematic review and meta-analysis of thermal ablation versus surgical nephrectomy for small renal tumours. Cardiovasc Interv Radiol. 2014;37(2):427–37.CrossRef
91.
Takaki H, Yamakado K, Soga N, Arima K, Nakatsuka A, Kashima M, et al. Midterm results of radiofrequency ablation versus nephrectomy for T1a renal cell carcinoma. Jpn J Radiol. 2010;28(6):460–8.PubMedCrossRef
92.
Thompson RH, Atwell T, Schmit G, Lohse CM, Kurup AN, Weisbrod A, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol. 2015;67(2):252–9.PubMedCrossRef
93.
Ma Y, Bedir S, Cadeddu JA, Gahan JC. Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours. BJU Int. 2014;113:51–5.PubMedCrossRef
94.
Breen DJ, Rutherford EE, Stedman B, Roy-Choudhury SH, Cast JEI, Hayes MC, et al. Management of renal tumors by image-guided radiofrequency ablation: experience in 105 tumors. Cardiovasc Interv Radiol. 2007;30(5):936–42.CrossRef
95.
Zagoria RJ, Pettus JA, Rogers M, Werle DM, Childs D, Leyendecker JR. Long-term outcomes after percutaneous radiofrequency ablation for renal cell carcinoma. Urology. 2011;77(6):1393–7.PubMedCrossRef
96.
Veltri A, Gazzera C, Busso M, Solitro F, Piccoli GB, Andreetto B, et al. T1a as the sole selection criterion for RFA of renal masses: randomized controlled trials versus surgery should not be postponed. Cardiovasc Interv Radiol. 2014;37(5):1292–8.CrossRef
97.
98.
Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, Weisbrod AJ, et al. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation. AJR Am J Roentgenol. 2013;200(2):461–6.PubMedCrossRef
99.
Zargar H, Atwell TD, Cadeddu JA, de la Rosette JJ, Janetschek G, Kaouk JH, et al. Cryoablation for small renal masses: selection criteria, complications, and functional and oncologic results. Eur Urol. 2016;69(1):116–28.PubMedCrossRef
100.
Zorn KC, Orvieto MA, Mikhail AA, Lyon MB, Gerber GS, Steinberg GD, et al. Case report: radiofrequency ablation-induced renal-pelvic obstruction resulting in nephrectomy. J Endourol. 2007;21(9):1059–63.PubMedCrossRef
101.
Park BK, Kim CK. Complications of image-guided radiofrequency ablation of renal cell carcinoma: causes, imaging features and prevention methods. Eur Radiol. 2009;19(9):2180–90.PubMedCrossRef
102.
Froghi S, Ahmed K, Khan MS, Dasgupta P, Challacombe B. Evaluation of robotic and laparoscopic partial nephrectomy for small renal tumours (T1a). BJU Int. 2013;112(4):E322–33.PubMedCrossRef
103.
Bhan SN, Pautler SE, Shayegan B, Voss MD, Goeree RA, You JJ. Active surveillance, radiofrequency ablation, or cryoablation for the nonsurgical management of a small renal mass: a cost-utility analysis. Ann Surg Oncol. 2013;20(11):3675–84.PubMedCrossRef
Metadata
Title
CIRSE Guidelines on Percutaneous Ablation of Small Renal Cell Carcinoma
Authors
Miltiadis E. Krokidis
Franco Orsi
Konstantinos Katsanos
Thomas Helmberger
Andy Adam
Publication date
01-02-2017
Publisher
Springer US
Published in
CardioVascular and Interventional Radiology / Issue 2/2017
Print ISSN: 0174-1551
Electronic ISSN: 1432-086X
DOI
https://doi.org/10.1007/s00270-016-1531-y

Other articles of this Issue 2/2017

CardioVascular and Interventional Radiology 2/2017 Go to the issue

Clinical Investigation

Prostate Zonal Volumetry as a Predictor of Clinical Outcomes for Prostate Artery Embolization

Review/State of the Art

Avoiding Complications in Bone and Soft Tissue Ablation

Case Report

Balloon-Occluded Retrograde Transvenous Obliteration of a Gastric Vascular Malformation: An Innovative Approach to Treatment of a Rare Condition

Clinical Investigation

Efficacy of a Self-expanding Tract Sealant Device in the Reduction of Pneumothorax and Chest Tube Placement Rates After Percutaneous Lung Biopsy: A Matched Controlled Study Using Propensity Score Analysis

Case Report

Recanalisation of Chronically Occluded Remote Superficial Femoral Artery Endarterectomy Through Angioplasty for Limb Salvage

Review

The Role of Interventional Oncology in the Management of Lung Cancer